Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hartford Hospital
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Cooper Hospital University Medical Center
Camden, New Jersey, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Cleveland Clinic Cancer Center/fairview Hospital
Cleveland, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Hillcrest Hospital Cancer Center
Mayfield Heights, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Oklahoma Cancer Specialists and Research Institute-Tulsa
Tulsa, Oklahoma, United States
- Women and Infants Hospital
Providence, Rhode Island, United States
- University of Virginia Cancer Center
Charlottesville, Virginia, United States
- Virginia Commonwealth University/massey Cancer Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Apr 2010
- Primary completion
- 4 Apr 2014
- Completion
- 27 Jan 2018
- Last update posted
- 9 Aug 2019
- Registered enrollment
- 33
- Registry id
- NCT01074411
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.